Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

QuikRead go CRP in primary care – NICE medtech innovation briefing

Products are for professional/laboratory use only.

The British National Institute for Health and Care Excellence (NICE) published a MIB on QuikRead go CRP test. The MIB provides a description of the QuikRead go CRP system, technology, including its likely place in therapy, the costs of using the technology and a critical review of the strengths and weaknesses of the relevant published evidence. The purpose of the briefing is to provide objective information on device and diagnostic technologies to aid local decision-making by healthcare pesonnel.

About the use of the QuikRead go CRP test the report states the following:
“The QuikRead go CRP test would be done at the point of care in primary care for people with suspected bacterial lower respiratory tract infection. It would be done by primary care clinicians during a consultation. The QuikRead go CRP test would only be used in conjunction with a clinical examination and clinical judgement to help inform the decision to prescribe antibiotics.”

Review the MIB

Click Here >

Contact us for a quote

Contact Us Now >



Request a Quote

Request Quote

Recent Posts

Devyser Genomic Blood Typing

A streamlined NGS solution for comprehensive blood typing, covering most relevant red blood cell, platelet, and neutrophil antigens in a single assay. Devyser Genomic Blood…

Read full article

Devyser Thalassemia v2

Thalassemia testing. Simplifed. Comprehensive NGS testing for thalassemia and sickle cell disease. Now with β-modifier detection, robust CNV analysis, and a streamlined workflow.Devyser Thalassemia v2…

Read full article

Bio-Techne – QuantideX® JAK2 V617F

Simplified, Sensitive, & Scalable JAK2 V617F Mutation DetectionThe QuantideX® qPCR JAK2 Kit delivers highly sensitive and quantitative detection of the JAK2 V617F mutation relative to…

Read full article